Heart Test Laboratories Inc. Common Stock (HSCS)vsMedtronic PLC (MDT)
HSCS
Heart Test Laboratories Inc. Common Stock
$1.94
-3.49%
HEALTHCARE · Cap: $6.18M
MDT
Medtronic PLC
$81.67
-0.16%
HEALTHCARE · Cap: $94.69B
Smart Verdict
WallStSmart Research — data-driven comparison
Medtronic PLC generates 409273256% more annual revenue ($35.48B vs $8,670). MDT leads profitability with a 13.0% profit margin vs 0.0%. MDT earns a higher WallStSmart Score of 61/100 (C+).
HSCS
Avoid28
out of 100
Grade: F
MDT
Buy61
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for HSCS.
Margin of Safety
+10.3%
Fair Value
$89.60
Current Price
$81.67
$7.93 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 654.0% year-over-year
Reasonable price relative to book value
Large-cap with strong market position
Reasonable price relative to book value
Strong operational efficiency at 20.0%
Generating 2.1B in free cash flow
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Elevated debt levels
Weak financial health signals
Earnings declined 11.8%
Comparative Analysis Report
WallStSmart ResearchBull Case : HSCS
The strongest argument for HSCS centers on Revenue Growth, Price/Book. Revenue growth of 654.0% demonstrates continued momentum.
Bull Case : MDT
The strongest argument for MDT centers on Market Cap, Price/Book, Operating Margin. PEG of 1.29 suggests the stock is reasonably priced for its growth.
Bear Case : HSCS
The primary concerns for HSCS are EPS Growth, Market Cap, Profit Margin.
Bear Case : MDT
The primary concerns for MDT are Piotroski F-Score, EPS Growth.
Key Dynamics to Monitor
HSCS profiles as a hypergrowth stock while MDT is a value play — different risk/reward profiles.
HSCS carries more volatility with a beta of 1.97 — expect wider price swings.
HSCS is growing revenue faster at 654.0% — sustainability is the question.
MDT generates stronger free cash flow (2.1B), providing more financial flexibility.
Bottom Line
MDT scores higher overall (61/100 vs 28/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Heart Test Laboratories Inc. Common Stock
HEALTHCARE · MEDICAL DEVICES · USA
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company is headquartered in Southlake, Texas.
Visit Website →Medtronic PLC
HEALTHCARE · MEDICAL DEVICES · USA
Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?